BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

  April 29, 2025

   · 

  15 min read
• Press Releases

  Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application

  April 29, 2025

   · 

  3 min read
• Press Releases

  Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance

  April 29, 2025

   · 

  23 min read
• Press Releases

  Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting

  April 29, 2025

   · 

  15 min read
• Press Releases

  Crescent Biopharma Appoints David Lubner to Board of Directors

  April 29, 2025

   · 

  2 min read
• Press Releases

  Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

  April 29, 2025

   · 

  3 min read
• Press Releases

  BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

  April 29, 2025

   · 

  6 min read
• Press Releases

  Chemomab Reports New Positive Clinical Data at EASL 2025 Supporting Nebokitug’s Impact in Primary Sclerosing Cholangitis and Related Diseases

  April 29, 2025

   · 

  8 min read
• Press Releases

  ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

  April 29, 2025

   · 

  4 min read
• Press Releases

  ImPact Biotech Presents Updated Efficacy Data from Evaluation of Padeliporfin VTP in LG UTUC and Intermediate-Risk Prostate Cancer at AUA 2025

  April 29, 2025

   · 

  6 min read